U, K., E, M., A, L., & AK, D. (2025). Co-Encapsulation of Doxorubicin HCl and Paclitaxel in Nanovesicles for Enhanced Breast Cancer Therapy. AAPS PharmSciTech, 27(1), 41. https://doi.org/10.1208/s12249-025-03299-x
Chicago Style (17th ed.) CitationU, Kafle, Moore E, Lushnikov A, and Dash AK. "Co-Encapsulation of Doxorubicin HCl and Paclitaxel in Nanovesicles for Enhanced Breast Cancer Therapy." AAPS PharmSciTech 27, no. 1 (2025): 41. https://doi.org/10.1208/s12249-025-03299-x.
MLA (9th ed.) CitationU, Kafle, et al. "Co-Encapsulation of Doxorubicin HCl and Paclitaxel in Nanovesicles for Enhanced Breast Cancer Therapy." AAPS PharmSciTech, vol. 27, no. 1, 2025, p. 41, https://doi.org/10.1208/s12249-025-03299-x.
Warning: These citations may not always be 100% accurate.